(Q35606373)

9 August 2017

1 reference

title

Cyclooxygenase-2 and prostaglandins in articular tissues (English)

1 reference

9 August 2017

Johanne Martel-Pelletier

series ordinal

1

object named as

Johanne Martel-Pelletier

1 reference

PubMed ID

14671726

9 August 2017

Jean-Pierre Pelletier

series ordinal

2

object named as

Jean-Pierre Pelletier

1 reference

9 August 2017

3

Hassan Fahmi

1 reference

9 August 2017

1 December 2003

1 reference

Seminars in Arthritis and Rheumatism

9 August 2017

1 reference

9 August 2017

33

1 reference

9 August 2017

155-167

1 reference

9 August 2017

3

1 reference

9 August 2017

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Inhibition of estradiol-induced early osteoarthritic changes by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Regulation of cyclooxygenase-2 expression in human mesangial cells - transcriptional inhibition by IL-13

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Involvement of two Sp1 elements in basal endothelial prostaglandin H synthase-1 promoter activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1beta in articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

An E-box region within the prostaglandin endoperoxide synthase-2 (PGS-2) promoter is required for transcription in rat ovarian granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Alternate COX-2 Transcripts Are Differentially Regulated: Implications for Post-Transcriptional Control

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Human glutathione dependent prostaglandin E synthase: gene structure and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Genetic and pharmacological analysis of prostanoid receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Regulation of type I collagen mRNA by amino acid deprivation in human lung fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

The effect of tumor necrosis factor alpha and gamma-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Intracellular signal transduction in proliferation of synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Induction of apoptosis in bovine articular chondrocyte by prostaglandin E(2) through cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

The contributions of cyclooxygenase-2 to tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Osteoarthritis management: the role of cyclooxygenase-2-selective inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Efficacy of cyclooxygenase-2-specific inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Cyclooxygenase-2: a major therapeutic advance?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

Induction of prostaglandin endoperoxide synthase-1 (COX-1) in a human promonocytic cell line by treatment with the differentiating agent TPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2803%2900134-3

7 January 2021

10.1016/S0049-0172(03)00134-3

Identifiers

DOI

1 reference

release_q4xhuv5aqjb5xpsha4h7lbu6si

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q4xhuv5aqjb5xpsha4h7lbu6si

24 November 2022

mapped directly with Wikidata item

PubMed ID

14671726

1 reference

PubMed ID

14671726